Table 5.
HIV program outcome indicators measured
| Indicator | Number of studies that assessed this indicator | Number of studies that reported a statistically significant favorable outcome on this indicator | Number of studies not showing a statistically significant favorable outcome on this indicator |
|---|---|---|---|
| % of women (or pregnant women) screened for HIV |
5 |
5 |
0 |
| % of HIV+ women (or pregnant women) initiating ART treatment |
5 |
4 |
1 |
| % of HIV+ infants who were retained in treatment |
3 |
3 |
0 |
| % of HIV+ children receiving ART with adequate viral suppression |
3 |
2 |
1 |
| Time to initiate ART after first ANC visit |
2 |
1 |
1 |
| Vertical transmission rate |
2 |
1 |
1 |
| % of HIV+ women linked to care |
1 |
1 |
0 |
| % of HIV+ women (or pregnant women) entering treatment who were retained in their treatment |
1 |
1 |
0 |
| % of HIV+ women with improved CD4+ cell count |
1 |
1 |
0 |
| % of women adhering to ART during the post-partum period |
1 |
1 |
0 |
| % of women retained in care during the post-partum period |
1 |
1 |
|
| ART coverage at delivery |
1 |
1 |
|
| % of women retained in care at delivery |
1 |
1 |
|
| % of women retained in care at infant HIV testing |
1 |
1 |
0 |
| % of women retained in care at infant ART initiation |
1 |
1 |
0 |
| % of children tested for HIV compared to non-intervention group |
1 |
1 |
0 |
| Incidence of HIV in HIV-exposed infants |
1 |
1 |
0 |
| % of HIV-exposed infants who tested HIV+ receiving ART within 3 d of birth |
1 |
1 |
0 |
| Average age of HIV+ infant/child in enrollment for ART | 1 | 1 | 0 |
ANC – antenatal care, ART – antiretroviral therapy